A new study led by the Royal National Orthopaedic Hospital NHS Trust will test an AI bone analysis tool that provides GPs with a patients’ risk of osteoporosis.
Designed to be used during routine x-rays, the tool will be examined for its potential to “increase the very low diagnosis rates” of the condition within the general population.
OsteoSight, the AI technology, will be trialled in a study led by Royal National Orthopaedic Hospital’s Professor Richard Keen and Dr Jude Bubbear, with funding through Innovate UK’s Precision Medicine programme.
The AI tool is said to “mimic the gold standard test for detecting osteoporosis”, with the introduction of the AI tool aiming to “capture people who might not have been otherwise screened” for the condition, and be used during routine x-rays.
Patients scheduled in for a hip x-ray will be asked whether they would like to take part in the study to learn more about their bone health, and those who sign up will help to test the ability of OsteoSight in predicting results.
Dr Catherine Kelly, COO at Naitive Technologies, said: “We are delighted to be partnering with Professor Keen and team at RNOH, to evaluate OsteoSight in a clinical NHS setting. This study signifies a critical step in proving the efficacy and real-world application of the technology, which aims to improve health outcomes in patients with poor bone health.”
Elsewhere in AI, University Hospitals of North Midlands has announced a £1.28 million AI upgrade to its radiology training facilities, thanks to funding from NHS England Midlands which aimed to support the development of a new training model at the Midlands Imaging Training Academy.
Also on the topic, University Hospitals Coventry and Warwickshire has collaborated with tech company IBM and data processing company Celonis to implement an artificial intelligence process mining tool, with the aim of helping the trust to better understand processes and where they could be improved.
